As hospitals report an increase in patients experiencing side effects from the unapproved weight-loss drug Retatrutide, health experts are raising alarms about its use. Despite not being approved anywhere in the world, the injectable peptide is being sold online and used by indi…
As obesity medications evolve, researchers are exploring new hormone combinations to enhance treatment effectiveness and tolerability. Current studies focus on therapies that not…
GLP-1 medications, while effective for weight loss and improving metabolic health, may also lead to emotional flatness in some users, described as the 'meh' effect. This phenomeno…
New research from Yale University has uncovered surprising effects of Ozempic, a GLP-1 medication, on hunger neurons in the brain. Contrary to previous beliefs that these neurons…
Research indicates that GLP-1 drugs, typically used for obesity treatment, may also effectively address polyendocrine metabolic ovarian syndrome (PMOS), a hormonal disorder affect…
Researchers at the University of Cambridge have discovered that both activating and blocking the glucose-dependent insulinotropic polypeptide receptor (GIPR) in different brain re…
The emergence of GLP-1 weight loss drugs, such as Ozempic and Wegovy, has transformed the landscape of obesity treatment, generating significant revenue for manufacturers and spar…
A recent study published in Nature reveals that rare mutations in the FNIP1 gene may help individuals burn fat instead of storing it, potentially lowering their risk of diabetes a…
The Health Products Regulatory Authority (HPRA) has confirmed over 1,500 reports of suspected adverse reactions related to anti-obesity medications, including serious gastrointest…
A recent clinical trial published in Nature Medicine reveals that aleniglipron, an oral GLP-1 medication, helped adults with obesity or overweight lose up to 12.1% of their body w…
A recent study from Yale University has uncovered a surprising mechanism by which GLP-1 therapies, like Ozempic, support sustained weight loss. Contrary to previous beliefs that t…
A new analysis by the King's Fund reveals that if obesity rates in England had remained at 1993 levels, there would be seven million fewer adults classified as obese today. The re…